» Authors » I Duris

I Duris

Explore the profile of I Duris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 72
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hulin I, Kinova S, Paulis L, Slavkovsky P, Duris I, Mravec B
Bratisl Lek Listy . 2010 May; 111(1):54-6. PMID: 20429314
Blood pressure measuring represents a routine investigation in general medicine. In the last decades large studies have determined average blood pressure values all around the world. Large clinical trials have...
2.
Valaskova Z, Kinova S, Danihel L, Duris I, Markovicova D, Mravec B, et al.
Vnitr Lek . 2010 Jan; 55(12):1145-58. PMID: 20070031
It was believed for rather a long time that the only components of tumour tissue are transformed cells characterised by hyper-proliferation, invasivity and immortalisation. Therapeutic strategies thus focused on autonomous...
3.
Kovacova E, Kinova S, Duris I, Remkova A
Bratisl Lek Listy . 2009 Jun; 110(5):280-4. PMID: 19507661
Disorders of haemostasis and haemocoagulation are often seen in cancer patients as a part of the paraneoplastic syndrome. This study describes a novel compound that activates coagulation and also inhibits...
4.
Kovacova E, Kinova S, Duris I, Remkova A
Bratisl Lek Listy . 2009 Jun; 110(4):215-21. PMID: 19507648
Disorders of haemostasis and haemocoagulation are often seen in patients with cancer as a part of paraneoplastic syndrome. Thrombotic and/or haemorrhagic complications are the second most common cause of mortality...
5.
Hulin I, Duris I, Paulis L, Sapakova E, Mravec B
Eur J Intern Med . 2009 Mar; 20(2):226-30. PMID: 19327617
The authors aim to offer a holistic view on hypertension and its treatment. Their approach is fairly confrontational, particularly by suggesting that hypertension may play a role in optimizing the...
6.
Hulin I, Duris I, Sapakova E, Paulis L, Mravec B
Cas Lek Cesk . 2008 Mar; 147(1):14-24. PMID: 18323038
Diagnosis of essential hypertension is created per exclusionem--with exclusion of all, so called secondary hypertensions (nephrogenic, endocrine conditioned etc). Idea and the name-essential hypertension are unclear. We have a lot...
7.
Al-Eryani S, Duris I, Huorka M, Payer J, Kratochvilova H, Ondrejka P
Ann Saudi Med . 2007 Feb; 21(1-2):9-12. PMID: 17264580
Background: Previous studies on gastrin levels in chronic pancreatitis (CP) patients have given conflicting results. These studies did not take into consideration the influence of Helicobacter pylori (H. pylori) infection...
8.
Ugorcakova J, Hlavaty T, Babal P, Janega P, Bukovska G, Halgasova N, et al.
Neoplasma . 2006 Oct; 53(5):363-71. PMID: 17013530
The aim of our work was to develop a fast, reliable and sensitive PCR method to detect K-ras mutations in various clinical samples. There is a need for an unimpeachable...
9.
Kovacova E, Salmas J, Stenova E, Bedeova J, Duris I
Bratisl Lek Listy . 2006 Apr; 106(12):386-9. PMID: 16642662
Behcet's syndrome is a systemic illness of unknown etiology characterized by necrotising vasculitis originally described in Turkey. Typical manifestations include urogenital ulcerations, eye inflammation and migratory thrombophlebitis. An unusual course...
10.
Hlavaty T, Lukac L, Huorka M, Bezayova T, Duris I
Bratisl Lek Listy . 2006 Mar; 106(10):318-23. PMID: 16541612
Background: Participation rates in colorectal cancer (CRC) screening are rather low. We evaluated the interest of first degree relatives (FDR) of CRC patients to participate in a colonoscopy screening and...